Mini Review - (2023) Volume 8, Issue 4
Received: 03-Jul-2023, Manuscript No. jbes-23-109459;
Editor assigned: 05-Jul-2023, Pre QC No. P-109459;
Reviewed: 17-Jul-2023, QC No. Q-109459;
Revised: 24-Jul-2023, Manuscript No. R-109459;
Published:
31-Jul-2023
, DOI: 10.37421/2736-6189.2023.8.336
Citation: Yahav, Dafna. “Emerging Infectious Diseases: A Global
Health Challenge.” Int J Pub Health Safety 8 (2023): 336.
Copyright: © 2023 Yahav D. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Emerging Infectious Diseases (EIDs) are a constant threat to global public health, representing a formidable challenge for scientists, healthcare professionals, policymakers and societies at large. These diseases are caused by newly identified or previously unknown infectious agents that have recently increased in incidence or geographic range. The unpredictable nature of EIDs and their potential to cause widespread outbreaks and pandemics demand continuous vigilance and rapid response to prevent and mitigate their impact. This article explores the complexities and implications of emerging infectious diseases as a critical global health challenge.
Global health • Infectious diseases • COVID-19
The dynamic nature of emerging infectious diseases
Infectious diseases have been part of the human experience since time immemorial. However, the emergence of new diseases and the resurgence of old ones present a complex and ever-changing landscape. Various factors contribute to the dynamic nature of EIDs:
Zoonotic origins: A significant proportion of EIDs have zoonotic origins, meaning they jump from animals to humans. Pathogens residing in wildlife reservoirs can cross the species barrier due to ecological changes, human encroachment into natural habitats and increased human-animal interactions. Examples include HIV/AIDS (from primates), Ebola (from bats or other wildlife) and COVID-19 (likely from bats, with potential intermediate hosts).
Antimicrobial resistance: The misuse and overuse of antimicrobial drugs have contributed to the development of resistant strains of bacteria, viruses and parasites. Antimicrobial resistance (AMR) poses a dual challenge, making infections more difficult to treat and limiting treatment options for both emerging and existing infectious diseases.
Globalization and travel: Modern travel and interconnectedness enable diseases to spread rapidly across borders and continents. A disease that emerges in one corner of the world can reach the opposite side within hours or days, as witnessed during the COVID-19 pandemic.
Environmental changes: Alterations in climate, land use and deforestation can influence disease dynamics. Vector-borne diseases, such as malaria and dengue fever, can expand their geographic range as the habitats of disease-carrying mosquitoes change.
Urbanization and population density: Increasing urbanization and population density in cities create fertile grounds for disease transmission, promoting rapid disease spread.
Notable examples of emerging infectious diseases
Throughout history, numerous EIDs have emerged and caused significant health crises. Some notable examples include:
HIV/AIDS: First recognized in the early 1980s, the human immunodeficiency virus (HIV) quickly spread globally, leading to one of the most devastating pandemics in history. As of the most recent data, over 38 million people have died from AIDS-related illnesses [1].
SARS-CoV: Severe Acute Respiratory Syndrome (SARS) emerged in 2002 in China and spread to multiple countries. Although it was contained relatively quickly, it highlighted the potential for global outbreaks due to international travel.
H1N1 Influenza (Swine Flu): The H1N1 influenza virus, a novel strain that originated in pigs, caused a pandemic in 2009, resulting in an estimated 151,700 to 575,400 deaths worldwide.
MERS-CoV: Middle East Respiratory Syndrome (MERS) was identified in Saudi Arabia in 2012. This coronavirus causes severe respiratory illness and has continued to sporadically emerge, mostly in the Arabian Peninsula.
Ebola virus disease: Outbreaks of Ebola have occurred in several African countries, causing severe hemorrhagic fever with high mortality rates. The largest outbreak, from 2014 to 2016 in West Africa, resulted in over 11,000 deaths.
Zika virus: The Zika virus, transmitted primarily by Aedes mosquitoes, emerged as a global health concern in 2015 due to its association with birth defects, particularly microcephaly, in babies born to infected mothers.
COVID-19: The coronavirus disease (COVID-19) pandemic, caused by the novel coronavirus SARS-CoV-2, was first identified in Wuhan, China, in late 2019. It rapidly spread worldwide, leading to millions of infections and deaths and overwhelming healthcare systems [2,3].
Challenges in responding to emerging infectious diseases
Early detection and surveillance: Early detection is crucial to implementing timely and targeted interventions. Improved global surveillance networks and rapid diagnostic tools are essential in identifying and monitoring potential emerging threats.
Vaccine development and deployment: Developing vaccines for novel pathogens is a complex and time-consuming process. Accelerated vaccine development strategies, as seen during the COVID-19 pandemic, are essential to deploy effective preventive measures promptly.
International collaboration: EIDs do not recognize borders, necessitating strong international cooperation in sharing information, resources and best practices to combat global health threats effectively [4].
Public health infrastructure: Robust public health infrastructure, including well-funded healthcare systems, strong surveillance capabilities and skilled healthcare personnel, is essential for a swift and coordinated response to outbreaks.
Risk communication: Transparent and effective risk communication is critical in gaining public trust, promoting adherence to public health measures and countering misinformation during outbreaks.
One health approach: Addressing EIDs requires a holistic approach that recognizes the interconnections between human, animal and environmental health. The One Health approach emphasizes collaboration among various sectors to tackle zoonotic diseases effectively [5].
Socioeconomic impact: EIDs can have severe socioeconomic consequences, particularly in vulnerable communities. Strategies to mitigate the impact on livelihoods and economies are essential to prevent exacerbating existing inequalities.
Emerging Infectious Diseases (EIDs) refer to diseases that have recently appeared in a population or are increasing in incidence or geographic range. These diseases may be caused by newly identified pathogens or by known pathogens that have undergone changes, allowing them to spread in new ways or to new populations. EIDs pose a significant threat to public health, as they can rapidly cause outbreaks and pandemics, often with severe consequences for human health and economies [6].
Causes of emerging infectious diseases
Zoonotic diseases: Many EIDs originate from animals and are transmitted to humans. Pathogens can jump from wildlife to humans directly or through intermediate hosts. Deforestation, urbanization and changes in human behavior bring people into closer contact with wildlife, increasing the likelihood of zoonotic spillover.
Globalization: The ease and speed of international travel and trade facilitate the rapid spread of infectious agents across borders, turning localized outbreaks into global threats.
Antimicrobial Resistance (AMR): The overuse and misuse of antibiotics and other antimicrobial drugs have led to the development of resistant strains of bacteria, viruses and parasites. These drug-resistant pathogens can cause more severe and challenging-to-treat infections.
Environmental changes: Changes in climate, land use and ecological disruptions can alter the habitats and distribution of disease vectors (such as mosquitoes and ticks) and reservoir hosts, leading to the emergence of new diseases in human populations.
Population dynamics: Human population growth, migration and urbanization can create conditions conducive to the spread of infectious diseases. Overcrowded living conditions, inadequate sanitation and limited access to healthcare contribute to disease transmission.
Notable examples of emerging infectious diseases
COVID-19: The coronavirus disease 2019 (COVID-19) pandemic caused by the novel coronavirus SARS-CoV-2 emerged in late 2019 in Wuhan, China. It quickly spread globally, leading to millions of infections and significant social and economic disruptions.
Ebola virus disease: Ebola outbreaks have occurred in several African countries, with the most extensive outbreak from 2014 to 2016 in West Africa resulting in over 11,000 deaths.
Zika virus: The Zika virus emerged as a global health concern in 2015 due to its association with birth defects, particularly microcephaly, in babies born to infected mothers.
H1N1 influenza (Swine Flu): The H1N1 influenza virus caused a pandemic in 2009, leading to an estimated 151,700 to 575,400 deaths worldwide.
Middle East respiratory syndrome (mers): MERS emerged in 2012 in Saudi Arabia and causes severe respiratory illness with a high mortality rate.
Challenges in managing emerging infectious diseases
Surveillance and early detection: Detecting and identifying EIDs early is crucial to mount an effective response. Surveillance systems, laboratory networks and rapid diagnostic capabilities are essential for early detection.
Research and vaccine development: Developing vaccines and treatments for newly emerging pathogens is a complex and time-consuming process. Research and development efforts must be accelerated during outbreaks to produce effective countermeasures.
Global cooperation: EIDs require international collaboration and information sharing among countries to prevent their spread and control outbreaks effectively.
Public health preparedness: Robust public health systems and preparedness plans are essential to respond swiftly to emerging threats and to minimize their impact on communities.
Risk communication: Effective risk communication is vital to inform the public, gain their trust and promote adherence to preventive measures during outbreaks.
Emerging infectious diseases continue to challenge humanity, posing a constant threat to global health security. The ongoing battle against these diseases demands a united and collaborative effort from the international community. By investing in research, surveillance, public health infrastructure and innovative medical technologies, societies can bolster their preparedness and response capabilities. Additionally, addressing the underlying factors driving the emergence of infectious diseases, such as deforestation, climate change and antimicrobial resistance, is crucial for preventing and mitigating future outbreaks. As history has shown, the only effective response to the global health challenge posed by emerging infectious diseases is through proactive, evidence-based and coordinated efforts on a global scale.
None.
None.
Google Scholar, Crossref, Indexed at
Google Scholar, Crossref, Indexed at
Google Scholar, Crossref, Indexed at
Google Scholar, Crossref, Indexed at
Google Scholar, Crossref, Indexed at
